134 related articles for article (PubMed ID: 22627606)
1. Psychopharmacological treatments in HIV patients under antiretroviral therapy.
Gallego L; Barreiro P; López-Ibor JJ
AIDS Rev; 2012; 14(2):101-11. PubMed ID: 22627606
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic medications and HIV.
Thompson A; Silverman B; Dzeng L; Treisman G
Clin Infect Dis; 2006 May; 42(9):1305-10. PubMed ID: 16586391
[TBL] [Abstract][Full Text] [Related]
3. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
Neuman MG; Monteiro M; Rehm J
Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
[TBL] [Abstract][Full Text] [Related]
4. [A nursing consultation to improve antiretroviral medication management in children].
Vaudre G; Dollfus C; Tabone MD; Courcoux MF; Portier E; Leverger G
Soins Pediatr Pueric; 2010; (256):35-8. PubMed ID: 20925307
[TBL] [Abstract][Full Text] [Related]
5. [HIV patients with psychiatric illnesses. Treatment strategies and drug interactions].
von Einsiedel RW; Berger T; Weisbrod M; Unverricht S; Hartmann M
Nervenarzt; 2001 Mar; 72(3):204-15. PubMed ID: 11268765
[TBL] [Abstract][Full Text] [Related]
6. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
7. Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.
Sattar SP; Schultz SK; Arndt S; Soundy T; Petty F
S D Med; 2007 Nov; 60(11):437, 439-41, 443 passim. PubMed ID: 18196687
[TBL] [Abstract][Full Text] [Related]
8. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
9. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens.
Patel N; Abdelsayed S; Veve M; Miller CD
Ann Pharmacother; 2011 Mar; 45(3):317-24. PubMed ID: 21386025
[TBL] [Abstract][Full Text] [Related]
10. Treatment-for-prevention: clinical considerations.
Lockman S; Sax P
Curr Opin HIV AIDS; 2012 Mar; 7(2):131-9. PubMed ID: 22227588
[TBL] [Abstract][Full Text] [Related]
11. [Saving on drugs, reducing side-effects. Treatment interruptions benefit acute and chronic HIV infected patients].
Jäger H
MMW Fortschr Med; 2002 Apr; 144 Suppl 1():8-11. PubMed ID: 12043085
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical care for HIV patients on directly observed therapy.
Foisy MM; Akai PS
Ann Pharmacother; 2004 Apr; 38(4):550-6. PubMed ID: 14990778
[TBL] [Abstract][Full Text] [Related]
13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
14. Use of club drugs by HIV-seropositive and HIV-seronegative gay and bisexual men.
Romanelli F; Smith KM; Pomeroy C
Top HIV Med; 2003; 11(1):25-32. PubMed ID: 12717048
[TBL] [Abstract][Full Text] [Related]
15. HIV & psychiatric disorders.
Chandra PS; Desai G; Ranjan S
Indian J Med Res; 2005 Apr; 121(4):451-67. PubMed ID: 15817956
[TBL] [Abstract][Full Text] [Related]
16. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease.
Catz SL; Kelly JA; Bogart LM; Benotsch EG; McAuliffe TL
Health Psychol; 2000 Mar; 19(2):124-33. PubMed ID: 10762096
[TBL] [Abstract][Full Text] [Related]
17. Psychopharmacology in HIV-infected patients.
Repetto MJ; Petitto JM
Psychosom Med; 2008 Jun; 70(5):585-92. PubMed ID: 18519881
[TBL] [Abstract][Full Text] [Related]
18. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
Wepner U
MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
[No Abstract] [Full Text] [Related]
19. Impact of adherence counseling dose on antiretroviral adherence and HIV viral load among HIV-infected methadone maintained drug users.
Cooperman NA; Heo M; Berg KM; Li X; Litwin AH; Nahvi S; Arnsten JH
AIDS Care; 2012; 24(7):828-35. PubMed ID: 22272732
[TBL] [Abstract][Full Text] [Related]
20. Management of common psychiatric conditions in the HIV-positive population.
Brogan K; Lux J
Curr HIV/AIDS Rep; 2009 May; 6(2):108-15. PubMed ID: 19358782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
